Dr. Kizzmekia “Kizzy” Shanta Corbett is a distinguished American viral immunologist whose groundbreaking research has revolutionized vaccine development. As an Assistant Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health and the Shutzer Assistant Professor at the Harvard Radcliffe Institute, Corbett is a leading voice in global health and scientific innovation. She gained worldwide recognition for her pivotal contributions to the development of the COVID-19 vaccine while working at the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).
Born on January 26, 1986, in Hurdle Mills, North Carolina, and raised in Hillsborough, North Carolina, Corbett displayed exceptional academic promise from a young age. Recognizing her talent, her fourth-grade teacher encouraged her family to enroll her in advanced academic programs. She later attended Orange High School, graduating in 2004, before earning a B.S. in Biological Sciences and Sociology from the University of Maryland, Baltimore County (UMBC) in 2008 as a Meyerhoff Scholar.
Determined to push the boundaries of scientific discovery, Corbett pursued a PhD in Microbiology and Immunology at the University of North Carolina at Chapel Hill (UNC-Chapel Hill), completing her doctoral studies in 2014. Her dissertation focused on human antibody responses to the dengue virus, further cementing her expertise in infectious diseases.
Corbett’s early career saw her gain invaluable research experience through internships and laboratory roles at UNC’s Kenan Labs, Stony Brook University, and the University of Maryland School of Nursing. From 2006 to 2009, she trained at the NIH under Dr. Barney S. Graham, focusing on respiratory syncytial virus (RSV) pathogenesis and vaccine platform innovations.
Her defining moment came when she joined the NIH’s Vaccine Research Center (VRC) in 2014 as a viral immunologist and research fellow. She played a leading role in developing vaccine antigens for Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). However, it was her work on COVID-19 vaccine development that made history. Corbett and her team developed a method to stabilize the coronavirus spike protein, significantly enhancing the vaccine’s effectiveness and manufacturability. This breakthrough directly contributed to the rapid development of Moderna’s mRNA COVID-19 vaccine, a major tool in combating the global pandemic.
Dr. Corbett’s contributions have earned her widespread recognition. In 2021, she was featured on Time’s “Time100 Next” list under the Innovators category, with a tribute written by Dr. Anthony Fauci. Her advocacy extends beyond research, as she actively champions STEM education and diversity in science. Through the U.S. State Department Speaker Program, she has delivered lectures worldwide, inspiring young scientists and advocating for underrepresented communities in STEM.
In 2025, Dr. Kizzmekia Corbett will make history as the first Black woman to travel with Blue Origin, the private spaceflight company founded by Jeff Bezos. Her journey into space symbolizes the boundless possibilities of scientific exploration and serves as an inspiration for future generations.
Dr. Corbett’s dedication to scientific innovation, public health, and mentorship continues to make an enduring impact. Her role in vaccine development, global health advocacy, and STEM empowerment solidifies her place as a true trailblazer.
Her recognition as one of the 100 Reputable Women of African Descent 2025 highlights her extraordinary achievements and unwavering commitment to science and society. Dr. Kizzmekia Corbett is not only a leader in immunology but also a symbol of progress, resilience, and inspiration for future generations.
Leave a comment